Relapse after treatment with peginterferon a-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B

被引：5
作者：
Flink, H. J.
Buster, E. H. C. J.
Merican, I.
Nevens, F.
Kitis, G.
Cianciara, J.
De Vries, R. A.
Hansen, B. E.
Schalm, S. W.
Janssen, H. L. A.
机构：
[1] Univ Med Ctr, Erasmus Mc, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands
[2] Hosp Selayang, Inst Med Res, Kuala Lumpur, Malaysia
[3] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Louvain, Belgium
[4] Heorge Papanikolaau Gen Reg Hosp, Dept Gastroenterol, Thessaloniki, Greece
[5] Med Acad Warsaw, Dept Hepatol, Warsaw, Poland
[6] Rijinstate Hosp, Dept Gastroenterol & Hepatol, Amhem, Netherlands
[7] Univ Rotterdam, Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[8] Univ Rotterdam, Med Ctr, Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
来源：
GUT | 2007年 / 56卷 / 10期
关键词：
D O I：
10.1136/gut.2007.125633
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1485 / 1486
页数：2
相关论文
共 9 条
[1]   Predicting relapse after cessation of lamivudine monotherapy for chronic hepatitis B virus infection [J].
Ito, K ;
Tanaka, Y ;
Orito, E ;
Hirashima, N ;
Ide, T ;
Hino, T ;
Kumashiro, R ;
Kato, A ;
Nukaya, H ;
Sakakibara, K ;
Mukaide, M ;
Ito, H ;
Sata, M ;
Ueda, R ;
Mizokami, M .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) :490-495
[2]   ANTIVIRAL EFFECT OF PROLONGED INTERMITTENT LYMPHOBLASTOID ALPHA INTERFERON TREATMENT IN CHRONIC HEPATITIS-B [J].
JANSSEN, HLA ;
BERK, L ;
SCHALM, SW ;
HEIJTINK, RA ;
HESS, G ;
ROSSOL, S ;
ZUMBUSCHENFELDE, KHM ;
CHAMULEAU, RAFM ;
JANSEN, PLM ;
REESINK, HW ;
MEYER, B ;
BEGLINGER, C ;
DENOUDENMULLER, JW ;
DEJONG, M ;
MULDER, CJJ .
GUT, 1992, 33 (08) :1094-1098
[3]   Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised [J].
Janssen, HLA ;
van Zonneveld, M ;
Senturk, H ;
Zeuzem, S ;
Akarca, US ;
Cakaloglu, Y ;
Simon, C ;
So, TMJ ;
Gerken, G ;
de Man, RA ;
Niesters, HGM ;
Zondervan, P ;
Hansen, B ;
Schalm, SW .
LANCET, 2005, 365 (9454) :123-129
[4]   LONG-TERM REMISSION OF CHRONIC HEPATITIS-B AFTER ALPHA-INTERFERON THERAPY [J].
KORENMAN, J ;
BAKER, B ;
WAGGONER, J ;
EVERHART, JE ;
DIBISCEGLIE, AM ;
HOOFNAGLE, JH .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (08) :629-634
[5]   Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B [J].
Lau, GKK ;
Piratvisuth, T ;
Luo, KX ;
Marcellin, P ;
Thongsawat, S ;
Cooksley, G ;
Gane, E ;
Fried, MW ;
Chow, WC ;
Paik, SW ;
Chang, WY ;
Berg, T ;
Flisiak, R ;
McCloud, P ;
Pluck, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2682-2695
[6]   Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea? [J].
Song, BC ;
Suh, DJ ;
Lee, HC ;
Chung, YH ;
Lee, YS .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (02) :124-129
[7]   Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B:: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase [J].
van Nunen, AB ;
Hansen, BE ;
Suh, DJ ;
Löhr, DJS ;
Chemello, L ;
Fontaine, H ;
Heathcote, J ;
Song, BC ;
Janssen, HLA ;
de Man, RA ;
Schalm, SW .
GUT, 2003, 52 (03) :420-424
[8]   Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B [J].
van Zonneveld, M ;
Honkoop, P ;
Hansen, BE ;
Niesters, HGM ;
Murad, SD ;
de Man, RA ;
Schalm, SW ;
Janssen, HLA .
HEPATOLOGY, 2004, 39 (03) :804-810
[9]   Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: Response and relapse rates, and factors related to durability of HBeAg seroconversion [J].
Yoon, SK ;
Jang, JW ;
Kim, CW ;
Bae, SH ;
Choi, JY ;
Choi, SW ;
Lee, YS ;
Lee, CD ;
Chung, KW ;
Sun, HS ;
Kim, BS .
INTERVIROLOGY, 2005, 48 (06) :341-349
1